Altimmune, Inc. (ALT)
USD 4.83
(0.73%)
USD 4.83
(0.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -76 Million | -62.58 Million | -78.23 Million | -34.43 Million | -9.6 Million | -9.38 Million |
| Net Income | -88.44 Million | -84.71 Million | -97.09 Million | -49.04 Million | -20.52 Million | -39.17 Million |
| Depreciation & Amortization | 477 Thousand | -205 Thousand | 551.3 Thousand | 298.05 Thousand | 387.32 Thousand | 302.36 Thousand |
| Deferred income taxes | -16.64 Million | - | 12.33 Million | -19.07 Thousand | -58.5 Thousand | -6.14 Million |
| Stock-based compensation | 10.64 Million | 8.1 Million | 5.51 Million | 2.57 Million | 1.26 Million | 773.24 Thousand |
| Change in working capital | -8.27 Million | 14.11 Million | -250.52 Thousand | -4.51 Million | 1.81 Million | 6.98 Million |
| Other non-cash items | 26.23 Million | 120 Thousand | 700 Thousand | 16.26 Million | 7.5 Million | 27.87 Million |
| Investing Cash Flow | 13.73 Million | -73.39 Million | 87.52 Million | -72.09 Million | -28.28 Million | -1 Million |
| Investments in PPE | -47 Thousand | -126 Thousand | -12.31 Million | -342.42 Thousand | -28.99 Thousand | -1.01 Million |
| Acquisitions | -13.77 Million | - | 194.53 Thousand | 138.46 Thousand | - | 14.49 Thousand |
| Investment purchases | -88.63 Million | -73.27 Million | -7.59 Million | -128.15 Million | -28.25 Million | - |
| Sales/Maturities of investments | 102.41 Million | - | 107.42 Million | 56.4 Million | - | - |
| Other Investing Activities | 13.77 Million | -73.27 Million | -194.53 Thousand | -138.46 Thousand | -28.28 Million | 14.49 Thousand |
| Financing Cash Flow | 86.3 Million | 56.78 Million | 65.09 Million | 213.48 Million | 12.53 Million | 32.48 Million |
| Debt repayment | - | - | - | -632 Thousand | -292 Thousand | -1.54 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -539 Thousand | -516 Thousand | 224.47 Million | 135.47 Million | 3.79 Billion | -2.38 Million |
| Common Stock Issuance | 86.92 Million | 56.78 Million | 65.21 Million | 213.48 Million | 12.69 Million | 37.4 Million |
| Other Financing Activities | -629 Thousand | 57.29 Million | 65.09 Million | 213.48 Million | 12.53 Million | -954.2 Thousand |
| Accounts receivables | -2.31 Million | 256 Thousand | 4.18 Million | -3.58 Million | 2.44 Million | 344.3 Thousand |
| Accounts payables | -2.73 Million | 2.77 Million | 1.42 Million | 594.06 Thousand | -354.62 Thousand | 243.06 Thousand |
| Inventory | 1.00 | - | - | - | -288.8 Thousand | 5.59 Million |
| Other working capital | -3.22 Million | 11.08 Million | -5.85 Million | -1.51 Million | 22.03 Thousand | 799.11 Thousand |
| Cash at beginning of period | 111.13 Million | 190.33 Million | 115.95 Million | 8.99 Million | 34.35 Million | 12.3 Million |
| Cash at end of period | 135.15 Million | 111.13 Million | 190.33 Million | 115.95 Million | 8.99 Million | 34.35 Million |
| Capital Expenditure | -47 Thousand | -126 Thousand | -12.31 Million | -342.42 Thousand | -28.99 Thousand | -1.01 Million |
| Effect of forex changes on cash | - | - | - | - | - | -50.36 Thousand |
| Net cash flow / Change in cash | 24.02 Million | -79.2 Million | 74.38 Million | 106.95 Million | -25.35 Million | 22.04 Million |
| Free Cash Flow | -76.05 Million | -62.71 Million | -90.54 Million | -34.77 Million | -9.63 Million | -10.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.64 Million | -24.39 Million | -31.64 Million | -88.44 Million | -20.67 Million | -16.06 Million |
| Depreciation & Amortization | 61 Thousand | 107 Thousand | 1.89 Million | 477 Thousand | -552 Thousand | -505 Thousand |
| Deferred income taxes | - | - | -7.54 Million | -16.64 Million | 197 Thousand | - |
| Stock-based compensation | 4.31 Million | 3.65 Million | 2.46 Million | 10.64 Million | 2.71 Million | 2.78 Million |
| Change in working capital | 3.15 Million | 5.25 Million | 821 Thousand | -8.27 Million | -1.97 Million | -5.48 Million |
| Other non-cash items | 4.94 Million | -1.07 Million | 17.47 Million | 26.23 Million | -199 Thousand | -114 Thousand |
| Investing Cash Flow | -3.69 Million | -39.52 Million | -7.95 Million | 13.73 Million | 4.4 Million | 3.98 Million |
| Investments in PPE | - | - | - | -47 Thousand | - | 4000.00 |
| Acquisitions | - | - | 17.33 Million | -13.77 Million | - | -3.98 Million |
| Investment purchases | -23.19 Million | -53.52 Million | -33.82 Million | -88.63 Million | -11.57 Million | -22.01 Million |
| Sales/Maturities of investments | 19.5 Million | 14 Million | 25.86 Million | 102.41 Million | 15.97 Million | 26 Million |
| Other Investing Activities | -3.69 Million | -39.52 Million | -7.95 Million | 13.77 Million | 4.4 Million | 3.98 Million |
| Financing Cash Flow | -46 Thousand | -261 Thousand | 72.75 Million | 86.3 Million | 588 Thousand | 13.24 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -244 Thousand | -600 Thousand | -37 Thousand | -539 Thousand | -2000.00 | -500 Thousand |
| Common Stock Issuance | 198 Thousand | 339 Thousand | 72.79 Million | 86.92 Million | 590 Thousand | 13.41 Million |
| Other Financing Activities | -244 Thousand | -600 Thousand | -37 Thousand | -629 Thousand | -2000.00 | -166 Thousand |
| Accounts receivables | -433 Thousand | 2.27 Million | -324 Thousand | -2.31 Million | -741 Thousand | 117 Thousand |
| Accounts payables | -1.07 Million | 1.69 Million | -976 Thousand | -2.73 Million | -989 Thousand | -1.2 Million |
| Inventory | - | - | - | 1.00 | - | - |
| Other working capital | 4.66 Million | 1.29 Million | 2.12 Million | -3.22 Million | -242 Thousand | -4.4 Million |
| Cash at beginning of period | 79.01 Million | 135.15 Million | 86.89 Million | 111.13 Million | 102.39 Million | 104.72 Million |
| Cash at end of period | 57.16 Million | 79.01 Million | 135.15 Million | 135.15 Million | 86.89 Million | 102.39 Million |
| Capital Expenditure | - | - | - | -47 Thousand | - | 4000.00 |
| Effect of forex changes on cash | - | - | -15.65 Million | - | 15.65 Million | - |
| Net cash flow / Change in cash | -21.85 Million | -56.13 Million | 48.26 Million | 24.02 Million | -15.49 Million | -2.33 Million |
| Free Cash Flow | -18.1 Million | -16.35 Million | -16.53 Million | -76.05 Million | -20.48 Million | -19.37 Million |
URG
0HTQ
HAYPP
BKTPF
SRCL
SAGA